The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma
Authors:
Open Access
- 17 February 2023
- journal article
- research article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 39, 100471
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangxi Province (20202BABL216015)
This publication has 35 references indexed in Scilit:
- Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axisGut, 2015
- JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cellsInternational Journal of Oncology, 2014
- Childhood and adolescent cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Risk Factors for Metastatic Disease at Presentation with OsteosarcomaJournal of Bone and Joint Surgery, 2013
- The role of Stat3 in glioblastoma multiformeJournal of Clinical Neuroscience, 2013
- A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processesBiochemical Pharmacology, 2010
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl IsothiocyanateJNCI: Journal of the National Cancer Institute, 2009
- Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyThe Lancet, 2005
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986